---
title: "Aventis Pharma Limited — Ownership Dossier"
canonical: https://whiteintel.dev/entity/461d0b17-3cd4-4179-bbf3-d77fb6f033a4
json: https://whiteintel.dev/api/public/dossier/461d0b17-3cd4-4179-bbf3-d77fb6f033a4
identifier: gb-coh:02945218
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Aventis Pharma Limited

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `gb-coh:02945218`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/461d0b17-3cd4-4179-bbf3-d77fb6f033a4  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/461d0b17-3cd4-4179-bbf3-d77fb6f033a4  

## Cross-source identity

The same real-world entity, resolved across sources:

- **AVENTIS PHARMA LIMITED** — GLEIF · `lei:549300FHMPUBGQQXOZ27` — https://whiteintel.dev/entity/c0e1fad2-5b7b-5c29-8141-0761a985dd63
- **AVENTIS PHARMA LIMITED** — companies_house_bulk · `oo:GB-COH-01535640` — https://whiteintel.dev/entity/26b300cb-b438-543f-aba7-0b4a6d47ca89

## Ownership & control

### Owners / controllers

- **AVENTIS PHARMA HOLDINGS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/280fd9a5-f230-5f82-98cb-fbe7b3e333ad
- **AVENTIS PHARMA LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/26b300cb-b438-543f-aba7-0b4a6d47ca89

### Holdings / subsidiaries

- **RHONE-POULENC RORER LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/f94e9f9e-6b6b-512f-acb9-b9f5dd44743d

### UBO chain (walk to the ultimate owner)

A **17-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `02945218`
- **Status:** dissolved
- **Type:** ltd
- **Incorporated:** 1994-06-29
- **Registered office:** 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, England
- **SIC:** 82990

### Officers

- BAIRD, Jessamy Rachel — director · British · appointed 2021-08-19
- KHAN, Usman — director · British · appointed 2021-03-31
- CLAPHAM, Christopher Edward — secretary · British · appointed 1994-06-29 · resigned 2001-06-30
- MCCLELLAN, Michael James — secretary · American · appointed 2008-02-13 · resigned 2010-05-12
- NICHOLLS, David John — secretary · British · appointed 2001-06-30 · resigned 2004-02-23
- ROBERTS, Helen — secretary · British · appointed 2004-12-20 · resigned 2008-01-30
- SMITH, Suzanne Elaine — secretary · British · appointed 2004-02-23 · resigned 2004-12-20
- ADAMS, Keith Graham — director · British · appointed 1994-06-29 · resigned 1994-09-26
- ASHTON, David Thomas — director · British · appointed 1997-12-16 · resigned 2000-02-18
- BENNETT, Clive Vincent — director · Canadian British · appointed 1997-12-08 · resigned 1999-12-16
- BROOKSBY, Nigel Stanley — director · British · appointed 2005-07-01 · resigned 2010-05-12
- CAMUS, Daniel — director · British · appointed 1994-09-01 · resigned 1996-07-22
- CHANCEL, Pierre — director · British · appointed 2004-05-19 · resigned 2009-05-16
- DE FORCEVILLE, Guillaume Adrien — director · French · appointed 2005-07-01 · resigned 2007-11-16
- DUHALDE, Francois-Xavier — director · French · appointed 2016-04-01 · resigned 2021-03-31
- DUNOYER, Marc — director · British · appointed 1994-09-01 · resigned 1995-03-20
- FRY, Hugo Rupert Alexander — director · British · appointed 2017-01-01 · resigned 2021-03-31
- GODARD, Jean Pierre — director · British · appointed 1994-09-01 · resigned 1996-07-22
- HOFSTAETTER, Walter Ulrich Thomas — director · British · appointed 1995-03-20 · resigned 1996-07-22
- JACQUESSON, Olivier — director · British · appointed 1994-09-01 · resigned 1997-12-08

### Beneficial owners (Persons with Significant Control)

- [Aventis Pharma Limited](https://whiteintel.dev/entity/26b300cb-b438-543f-aba7-0b4a6d47ca89) — 75–100% shares · corporate PSC · England — since 2021-01-25
- [Aventis Pharma Holdings Limited](https://whiteintel.dev/entity/280fd9a5-f230-5f82-98cb-fbe7b3e333ad) — 75–100% shares · corporate PSC · England — ceased 2021-01-25

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Aventis Pharma Limited**. Human view: https://whiteintel.dev/entity/461d0b17-3cd4-4179-bbf3-d77fb6f033a4 · Structured JSON: https://whiteintel.dev/api/public/dossier/461d0b17-3cd4-4179-bbf3-d77fb6f033a4._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._